Operating Lease, Right-of-Use Asset of Benitec Biopharma Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Benitec Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Benitec Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $755,000, a 270% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Benitec Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $755,000 +$551,000 +270% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 $860,000 +$590,000 +219% 30 Jun 2025 10-Q 14 Nov 2025 2026 Q1
Q1 2025 $964,000 +$629,000 +188% 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $137,000 -$263,000 -66% 31 Dec 2024 10-Q 14 Feb 2025 2024 Q2
Q3 2024 $204,000 -$259,000 -56% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $270,000 -$256,000 -49% 30 Jun 2024 10-K 22 Sep 2025 2025 FY
Q1 2024 $335,000 -$254,000 -43% 31 Mar 2024 10-Q 13 May 2024 2024 Q3
Q4 2023 $400,000 -$250,000 -38% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q2
Q3 2023 $463,000 -$248,000 -35% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q1
Q2 2023 $526,000 -$245,000 -32% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q1 2023 $589,000 -$239,000 -29% 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 $650,000 -$238,000 -27% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q2
Q3 2022 $711,000 -$236,000 -25% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q1
Q2 2022 $771,000 $0 0% 30 Jun 2022 10-K 26 Sep 2024 2024 FY
Q1 2022 $828,000 +$576,000 +229% 31 Mar 2022 10-Q 16 May 2022 2022 Q3
Q4 2021 $888,000 +$588,000 +196% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $947,000 +$599,000 +172% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q2 2021 $771,000 +$376,000 +95% 30 Jun 2021 10-K 21 Sep 2023 2023 FY
Q1 2021 $252,000 31 Mar 2021 10-Q 12 May 2021 2021 Q3
Q4 2020 $300,000 31 Dec 2020 10-Q 09 Feb 2021 2021 Q2
Q3 2020 $348,000 30 Sep 2020 10-Q 13 Nov 2020 2021 Q1
Q2 2020 $395,000 30 Jun 2020 10-K 20 Sep 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.